PharmEasy Founders Commit to Retaining Thyrocare and Reducing Cash Burn PharmEasy ‘s founders informed the Board earlier this month that they will not sell Thyrocare, the company’s diagnostic division. The move comes as the e-pharmacy struggles to raise new funds as a result of the broader tech downturn. PharmEasy’s parent company, API Holdings, has also … Continue reading PharmEasy Founders: Will Not Sell Thyrocare and Will Cut Cash Burn